Insiders · ALPN

Mitchell Gold

Executive Chairman and CEO, Director at Alpine Immune Sciences, Inc. (ALPN)

Mitchell Gold has filed 19 insider reports with the SEC since February 2021, as executive Chairman and CEO and director at Alpine Immune Sciences, Inc. (ALPN). Mitchell Gold made no open-market purchases or sales in the last 12 months. The latest filing, on May 21, 2024, reports sale back to the company and tender of shares in a change of control at Alpine Immune Sciences, Inc. (ALPN).

Filings
19
Companies
1
Bought on market
None
Sold on market
$10.1M

Companies where Mitchell Gold is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Alpine Immune Sciences, Inc. logo
ALPN
Alpine Immune Sciences, Inc.
Executive Chairman and CEO, Director0$10.1MMay 21, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Mitchell Gold with

Questions about Mitchell Gold

What is Mitchell Gold's role at Alpine Immune Sciences, Inc.?
Mitchell Gold reports to the SEC as executive Chairman and CEO and director at Alpine Immune Sciences, Inc. (ALPN), according to the latest filing on May 21, 2024.
Has Mitchell Gold bought or sold stock recently?
The most recent open-market sale was on December 28, 2023: sold 1,016 shares of Alpine Immune Sciences, Inc. (ALPN) for $20.4K at an average of $20.04.
How do I get alerts when Mitchell Gold files?
Follow Mitchell Gold on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Mitchell Gold (SEC CIK 0001242882). Totals count each trade once, skipping amendments whose original is on file, from Feb 3, 2021 on. View on SEC EDGAR